FAKTOR OPTIONSSCHEIN - MERCK & CO. | Market Closed - Boerse Frankfurt Warrants 01:27:32 2024-05-31 pm EDT | ||
| 4.12 EUR | +5.64% |
|
| Current month | +8.99% | ||
| 1 month | +8.99% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 4.12 | +5.64% |
| 24-05-30 | 3.9 | -4.41% |
| 24-05-29 | 4.08 | +1.24% |
| 24-05-28 | 4.03 | +9.21% |
| 24-05-27 | 3.69 | -1.34% |
Real-time Boerse Frankfurt Warrants
Last update May 31, 2024 at 01:27 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | UBS |
| WKN | UM0K9D |
| ISIN | DE000UM0K9D0 |
| Date issued | 2024-01-25 |
| Strike | 166 $ |
| Maturity | Unlimited |
| Parity | 9.05 : 1 |
| Emission price | 5.02 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.01 € |
|---|---|
| Lowest since issue | 3.47 € |
| Spread | 0.05 € |
| Spread % | 1.21% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5
USD
Average target price
141.9
USD
Spread / Average Target
+13.01%
- Stock Market
- Certificates
- Certificat
